Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02951091 | Biomarker-Integrated Umbrella, Advanced Gastric Cancer | completed | N/A | 400 | Yonsei UniversityOTHER | 1 | Dec 30, 2024 | clinicaltrials |
| NCT01286766 | Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric Adenocarcinoma | completed | Phase 2 | 6 | Yonsei UniversityOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT04164069 |
| Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab |
| completed |
| Phase 1 |
| 9 |
| Anne NoonanOTHER |
| 1 |
| Dec 27, 2024 |
| clinicaltrials |
| NCT04028479 | The Registry of Oncology Outcomes Associated With Testing and Treatment(ROOT) | completed | — | 167 | Taproot HealthINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT03878472 | Neoadjuvant Immunotherapy for Resectable Gastric Cancer | completed | Phase 2 | 25 | Qilu Hospital of Shandong UniversityOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT03698825 | TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer | completed | Phase 1 / Phase 2 | 62 | MedPacto, Inc.INDUSTRY | 1 | Dec 9, 2024 | clinicaltrials |
| NCT04319757 | ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors | completed | Phase 1 | 12 | Acepodia Biotech, Inc.INDUSTRY | 2 | Dec 5, 2024 | clinicaltrials |
| NCT06716593 | Trajectory of Body Composition Identifies LAGC with Cachexia Following NACT(FJMUGS-2411) | completed | — | 600 | Chang-Ming Huang, Prof.OTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT03528629 | A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma | completed | N/A | 18 | Astellas Pharma IncINDUSTRY | 1 | Dec 2, 2024 | clinicaltrials |
| NCT03978481 | Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study | completed | — | 3,700 | Seoul National University Bundang HospitalOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT04602689 | Fibrin Glue After ESD for High Risk Patients of Bleeding | completed | N/A | 134 | Seoul National University HospitalOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT06663852 | ML Decision Model for G-NEC Adjuvant Therapy(G-NEC) | completed | — | 1,505 | Chang-Ming Huang, Prof.OTHER | 1 | Nov 27, 2024 | clinicaltrials |
| NCT06706466 | Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy. | completed | — | 410 | Chang-Ming Huang, Prof.OTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT06697821 | The Number of Mesogastria Containing Metastatic Lymph Nodes Predicts Gastric Cancer Prognosis | completed | — | 480 | Jichao QinOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT04989816 | Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens(DG-06) | completed | Phase 2 | 95 | AstraZenecaINDUSTRY | 1 | Nov 21, 2024 | clinicaltrials |
| NCT05646290 | Validation of a Model for Predicting Anastomotic Leakage | completed | — | 512 | Jichao QinOTHER | 1 | Nov 21, 2024 | clinicaltrials |
| NCT06696963 | Impact of TTC Following Neoadjuvant Chemotherapy on the Prognosis of LAGC | completed | — | 524 | Fujian Medical UniversityOTHER | 1 | Nov 20, 2024 | clinicaltrials |
| NCT04250402 | The Incidence of Gallstones After Gastric Cancer Surgery | completed | — | 1,019 | Hepatopancreatobiliary Surgery Institute of Gansu ProvinceOTHER | 1 | Nov 19, 2024 | clinicaltrials |
| NCT05965466 | The Incidence of Gallstones After Gastrectomy | completed | N/A | 531 | Hepatopancreatobiliary Surgery Institute of Gansu ProvinceOTHER | 1 | Nov 19, 2024 | clinicaltrials |
| NCT06690268 | Multimodal Model Predicts Recurrence(FUTURE12) | completed | — | 93 | Qun ZhaoOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT04292496 | Anastomotic Leak Testing in Gastrectomy | completed | N/A | 148 | Nanchong Central HospitalOTHER_GOV | 1 | Nov 14, 2024 | clinicaltrials |
| NCT06689462 | Appraisal of the Modified Cancer Cachexia Index in Locally Advanced Gastric Cancer Patients Undergoing Neoadjuvant Chemotherapy | completed | — | 600 | Fujian Medical UniversityOTHER | 1 | Nov 14, 2024 | clinicaltrials |
| NCT02578368 | Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction(FLOT5) | completed | Phase 3 | 183 | Krankenhaus NordwestOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06673472 | Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric Cancer | completed | — | 1,081 | Chang-Ming Huang, Prof.OTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT04871204 | Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer(OTIS) | completed | Phase 2 | 20 | Fredrik KlevebroOTHER | 1 | Oct 31, 2024 | clinicaltrials |
| NCT06666582 | Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer | completed | — | 185 | Hellenic Cooperative Oncology GroupOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT03427814 | Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer | completed | Phase 2 | 136 | BeiGeneINDUSTRY | 16 | Oct 26, 2024 | clinicaltrials |
| NCT02040142 | HIPEC for Peritoneal Carcinomatosis | completed | Phase 2 | 51 | Albert Einstein College of MedicineOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT05427214 | Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy(Dragon) | completed | N/A | 52 | Washington University School of MedicineOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT06645912 | Effect of High Protein ONS on Older Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy | completed | N/A | 46 | Erzincan Binali Yildirim University Mengucek Gazi Training and Research HospitalOTHER_GOV | 1 | Oct 18, 2024 | clinicaltrials |
| NCT04861987 | A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors | completed | Phase 1 | 23 | Processa PharmaceuticalsINDUSTRY | 1 | Oct 10, 2024 | clinicaltrials |
| NCT00582257 | Early Onset and Familial Gastric Cancer Registry | completed | — | 971 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Oct 3, 2024 | clinicaltrials |
| NCT04713891 | A Study of KF-0210 in Advanced Solid Tumors Patients | completed | Phase 1 | 14 | Keythera Pharmaceuticals (Australia) Pty LtdINDUSTRY | 1 | Sep 24, 2024 | clinicaltrials |
| NCT04253106 | Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer(LISA-HDGC) | completed | N/A | 16 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT02845479 | The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I(POISE) | completed | Phase 3 | 22 | The Canadian College of Naturopathic MedicineOTHER | 1 | Sep 20, 2024 | clinicaltrials |
| NCT00400179 | A Safety and Efficacy Study in Patients With Gastric Cancer | completed | Phase 3 | 1,053 | Taiho Oncology, Inc.INDUSTRY | 2 | Sep 19, 2024 | clinicaltrials |
| NCT02891447 | Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03453164 | Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT) | completed | Phase 1 / Phase 2 | 41 | Fukushima Medical UniversityOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04065139 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study(PIPAC EstoK 01) | completed | Phase 2 | 66 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT00072787 | Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 41 | Taiho Oncology, Inc.INDUSTRY | 1 | Sep 3, 2024 | clinicaltrials |
| NCT02500043 | Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer | completed | Phase 3 | 507 | Taiho Oncology, Inc.INDUSTRY | 18 | Sep 3, 2024 | clinicaltrials |
| NCT06573307 | Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Neoadjuvant Therapy | completed | — | 442 | Chang-Ming Huang, Prof.OTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06561516 | Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer | completed | N/A | 60 | Gangnam Severance HospitalOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT06563063 | Finding ED90 of Flumazenil for Selective Improvement of Respiratory Distress by Remimazolam | completed | N/A | 60 | Yonsei UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT06548464 | Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients | completed | — | 18,000 | Chang-Ming Huang, Prof.OTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT03647969 | Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer | completed | Phase 2 | 262 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT03133286 | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)(RADIANT) | completed | — | 16 | DxTerity DiagnosticsINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT03852251 | A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma | completed | Phase 1 / Phase 2 | 338 | AkesoINDUSTRY | 1 | Aug 2, 2024 | clinicaltrials |
| NCT02443324 | A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer | completed | Phase 1 | 175 | Eli Lilly and CompanyINDUSTRY | 6 | Jul 31, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Dec 30, 2024source: clinicaltrials